MERIDIAN BIOSCIENCE, INC. Royalty Income, Nonoperating
MERIDIAN BIOSCIENCE, INC. reported Royalty Income, Nonoperating of $1.65 million for the 3-month period ending 2022-12-31, per its 10-Q filed 2023-02-09.
Discontinued › Income Statement › Other Income
us-gaap:RoyaltyIncomeNonoperating · last filed 2023-02-09
- MERIDIAN BIOSCIENCE, INC. royalty income, nonoperating for the quarter ending 2022-12-31 was $1.65M, a 58.65% increase year-over-year.
- MERIDIAN BIOSCIENCE, INC. royalty income, nonoperating for the quarter ending 2022-09-30 was $1.12M, a 10.04% decline year-over-year.
- MERIDIAN BIOSCIENCE, INC. royalty income, nonoperating for the quarter ending 2022-06-30 was $2.08M, a 50.72% increase year-over-year.
- MERIDIAN BIOSCIENCE, INC. royalty income, nonoperating for the quarter ending 2022-03-31 was $2.58M, a 9.47% decline year-over-year.
- MERIDIAN BIOSCIENCE, INC. royalty income, nonoperating for fiscal 2022 was $6.75M, a 6.64% increase from fiscal 2021.
- MERIDIAN BIOSCIENCE, INC. royalty income, nonoperating for fiscal 2021 was $6.33M, a 78.81% increase from fiscal 2020.
- MERIDIAN BIOSCIENCE, INC. royalty income, nonoperating for fiscal 2020 was $3.54M, a 2.91% increase from fiscal 2019.
- MERIDIAN BIOSCIENCE, INC. royalty income, nonoperating for fiscal 2019 was $3.44M.
| Period end | Royalty Income, Nonoperating 3 month | Royalty Income, Nonoperating 3 month as first filed | Royalty Income, Nonoperating 6 month | Royalty Income, Nonoperating 6 month as first filed | Royalty Income, Nonoperating 9 month | Royalty Income, Nonoperating 12 month |
|---|---|---|---|---|---|---|
| 2022-12-31 | $1.65M 10-Q · filed 2023-02-09 | $2.77M derived: sum of 2 quarters · filed 2023-02-09 | $4.85M derived: sum of 3 quarters · filed 2023-02-09 | $7.43M derived: sum of 4 quarters · filed 2023-02-09 | ||
| 2022-09-30 | $1.12M derived: 10-K 12 month − 10-Q 9 month · filed 2022-11-22 | $3.20M derived: sum of 2 quarters · filed 2022-11-22 | $5.78M derived: sum of 3 quarters · filed 2022-11-22 | $6.75M 10-K · filed 2022-11-22 | ||
| 2022-06-30 | $2.08M 10-Q · filed 2022-08-05 | $4.66M derived: sum of 2 quarters · filed 2022-08-05 | $5.63M 10-Q · filed 2022-08-05 | $6.95M derived: sum of 4 quarters · filed 2023-02-09 | ||
| 2022-03-31 | $2.58M 10-Q · filed 2022-05-06 | $3.55M 10-Q · filed 2022-05-06 | $4.87M derived: sum of 3 quarters · filed 2023-02-09 | $6.25M derived: sum of 4 quarters · filed 2023-02-09 | ||
| 2021-12-31 | $1.04M 10-Q · filed 2023-02-09 | $2.29M derived: sum of 2 quarters · filed 2023-02-09 | $3.67M derived: sum of 3 quarters · filed 2023-02-09 | $6.51M derived: sum of 4 quarters · filed 2023-02-09 | ||
| 2021-09-30 | $1.25M derived: 10-K 12 month − 10-Q 9 month · filed 2022-11-22 | $2.63M derived: sum of 2 quarters · filed 2022-11-22 | $5.47M derived: sum of 3 quarters · filed 2022-11-22 | $6.33M 10-K · filed 2022-11-22 | ||
| 2021-06-30 | $1.38M 10-Q · filed 2022-08-05 | $4.23M derived: sum of 2 quarters · filed 2022-08-05 | $5.08M 10-Q · filed 2022-08-05 | $6.26M derived: sum of 4 quarters · filed 2022-11-22 | ||
| 2021-03-31 | $2.85M 10-Q · filed 2022-05-06 | $2.85M 10-Q · filed 2021-05-07 | $3.71M 10-Q · filed 2022-05-06 | $3.71M 10-Q · filed 2021-05-07 | $4.88M derived: sum of 3 quarters · filed 2022-11-22 | $5.04M derived: sum of 4 quarters · filed 2022-11-22 |
| 2020-12-31 | $860.00K 10-Q · filed 2022-02-04 | $2.04M derived: sum of 2 quarters · filed 2022-11-22 | $2.19M derived: sum of 3 quarters · filed 2022-11-22 | $3.48M derived: sum of 4 quarters · filed 2022-11-22 | ||
| 2020-09-30 | $1.18M derived: 10-K 12 month − 10-Q 9 month · filed 2022-11-22 | $1.33M derived: sum of 2 quarters · filed 2022-11-22 | $2.62M derived: sum of 3 quarters · filed 2022-11-22 | $3.54M 10-K · filed 2022-11-22 | ||
| 2020-06-30 | $160.00K 10-Q · filed 2021-08-06 | $1.44M derived: sum of 2 quarters · filed 2021-08-06 | $2.37M 10-Q · filed 2021-08-06 | |||
| 2020-03-31 | $1.28M 10-Q · filed 2021-05-07 | $2.21M 10-Q · filed 2021-05-07 | ||||
| 2019-09-30 | $3.44M 10-K · filed 2021-11-23 |